Healthcare Triangle (HCTI) EBIT (2020 - 2026)

Healthcare Triangle has disclosed EBIT across 7 years of filings, most recently posting -$3.6 million for Q1 2026.

• EBIT for Q1 2026 came in at -$3.6 million, down 159.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.0 million (down 170.57% YoY), and the FY2025 annual result was -$9.8 million, down 106.04% from the prior year.
• EBIT came in at -$3.6 million for Q1 2026 at Healthcare Triangle, up from -$4.4 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$498000.0 in Q4 2024 to a low of -$10.7 million in Q4 2022.
• The 5-year median for EBIT is -$1.6 million (2023), against an average of -$2.5 million.
• Across the five-year window, EBIT soared 87.19% in 2023 and slumped 792.17% in 2025, its largest moves.
• Healthcare Triangle's EBIT stood at -$10.7 million in 2022, then jumped by 87.19% to -$1.4 million in 2023, then jumped by 63.57% to -$498000.0 in 2024, then plunged by 792.17% to -$4.4 million in 2025, then climbed by 18.46% to -$3.6 million in 2026.
• The last three EBIT figures came in at -$3.6 million (Q1 2026), -$4.4 million (Q4 2025), and -$2.6 million (Q3 2025), per Business Quant data.